secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chiron Real Estate Inc. (XRN)
CIK:        0001533615
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001104659-26-019760
Event type: earnings
Sentiment:  neutral
Materiality: 0.70
Item codes: 2.02, 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chiron (XRN) Q4 Core FFO $1.16/sh (+6.4% YoY); FY26 Core FFO guide $4.30-$4.45; switches to monthly dividend
--------------------------------------------------------------------------------

- Q4 GAAP net loss $7.4M ($0.55/sh) vs. prior year net income $1.4M ($0.10/sh).
- Q4 Core FFO $1.16/sh, up 6.4% YoY; same-property Cash NOI growth 5.4% YoY.
- Full year 2026 Core FFO guidance $4.30-$4.45 per share; no debt maturities in 2026/27.
- Dividend switched from quarterly to monthly at $0.25/sh ($3.00 annualized, unchanged); White Rock Medical tenant filed Chapter 11.
- Completed $51.3M Series B preferred offering; company renamed from Global Medical REIT to Chiron (XRN).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1533615/000110465926019760/0001104659-26-019760-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1533615/000110465926019760/tm267304d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-019760

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer